Göke B - Search Results

1

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Göke B, Gallwitz B, Eriksson J, Hellqvist A, Gause-Nilsson I; D1680C00001 Investigators. Göke B, et al. Int J Clin Pract. 2010 Nov;64(12):1619-31. doi: 10.1111/j.1742-1241.2010.02510.x. Epub 2010 Sep 16. Int J Clin Pract. 2010. PMID: 20846286 Clinical Trial.

2

Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial.

Göke B, Gallwitz B, Eriksson JG, Hellqvist Å, Gause-Nilsson I. Göke B, et al. Int J Clin Pract. 2013 Apr;67(4):307-16. doi: 10.1111/ijcp.12119. Int J Clin Pract. 2013. PMID: 23638466 Clinical Trial.

3

The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetes.

Göke B, Gause-Nilsson I, Persson A; GALLANT 8 Study Group. Göke B, et al. Diab Vasc Dis Res. 2007 Sep;4(3):204-13. doi: 10.3132/dvdr.2007.041. Diab Vasc Dis Res. 2007. PMID: 17907110 Free article. Clinical Trial.

4

Islet cell function is as interesting as insulin resistance for T2DM treatment options.

Göke B. Göke B. Int J Clin Pract Suppl. 2008 Mar;(159):1. doi: 10.1111/j.1742-1241.2007.01684.x. Int J Clin Pract Suppl. 2008. PMID: 18269434 No abstract available.

5

Efficacy and safety of vildagliptin monotherapy during 2-year treatment of drug-naïve patients with type 2 diabetes: comparison with metformin.

Göke B, Hershon K, Kerr D, Calle Pascual A, Schweizer A, Foley J, Shao Q, Dejager S. Göke B, et al. Horm Metab Res. 2008 Dec;40(12):892-5. doi: 10.1055/s-0028-1082334. Epub 2008 Aug 22. Horm Metab Res. 2008. PMID: 18726829 Clinical Trial.

6

Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.

Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B. Woerle HJ, et al. Among authors: goke b. Diabetes Res Clin Pract. 2007 Aug;77(2):280-5. doi: 10.1016/j.diabres.2006.11.011. Epub 2007 Jan 22. Diabetes Res Clin Pract. 2007. PMID: 17240473 Clinical Trial.

7

Islet cell function: alpha and beta cells--partners towards normoglycaemia.

Göke B. Göke B. Int J Clin Pract Suppl. 2008 Mar;(159):2-7. doi: 10.1111/j.1742-1241.2007.01686.x. Int J Clin Pract Suppl. 2008. PMID: 18269435 Review.

8

Effect of pioglitazone on lipids in well controlled patients with diabetes mellitus type 2 -- results of a pilot study.

Parhofer KG, Otto C, Geiss HC, Laubach E, Göke B. Parhofer KG, et al. Among authors: goke b. Exp Clin Endocrinol Diabetes. 2005 Jan;113(1):49-52. doi: 10.1055/s-2004-830527. Exp Clin Endocrinol Diabetes. 2005. PMID: 15662596 Clinical Trial.

9

Improved glycemic control and lipid profile in a randomized study of pioglitazone compared with acarbose in patients with type 2 diabetes mellitus.

Göke B; German Pioglitazone Study Group. Göke B, et al. Treat Endocrinol. 2002;1(5):329-36. doi: 10.2165/00024677-200201050-00005. Treat Endocrinol. 2002. PMID: 15832486 Clinical Trial.

10

Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study.

Beigel F, Teich N, Howaldt S, Lammert F, Maul J, Breiteneicher S, Rust C, Göke B, Brand S, Ochsenkühn T. Beigel F, et al. Among authors: goke b. J Crohns Colitis. 2014 Nov;8(11):1471-9. doi: 10.1016/j.crohns.2014.05.009. Epub 2014 Jun 19. J Crohns Colitis. 2014. PMID: 24953836 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

511 results

Search Page